PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Harvard T. H. Chan School of Public Health, Boston, MA, USA.\', \'Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.\', \'Erasmus MC, University Medical Center Rotterdam, Department of Public Health, Rotterdam, Netherlands.\', \'Cancer Research Division, Cancer Council NSW, Sydney, Australia.\', \'School of Public Health, University of Sydney, Sydney, Australia.\', \'Massachusetts General Hospital, Boston, MA, USA.\', \'National Cancer Institute, Division of Cancer Control and Population Sciences, Rockville, MD, USA.\', \'Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/09691413211001097
?:hasPublicationType
?:journal
  • Journal of medical screening
is ?:pmid of
?:pmid
?:pmid
  • 33730899
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.209
?:rankingScore_hIndex
  • 56
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of COVID-19-related care disruptions on cervical cancer screening in the United States.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all